Effectively Developing Cutting-edge Mobile Tools for Market Access
This webinar explained how to conceptualize, optimize, and kick-off your mobile tool development process.
This webinar explained how to conceptualize, optimize, and kick-off your mobile tool development process.
This webinar explained how the latest updates in the Simcyp Simulator v19, Certara’s physiologically-based pharmacokinetic (PBPK) modeling and simulation platform, will support developing safer, more effective medications faster.
High prices for drugs for rare diseases have introduced uncertainties from payers around whether a medication’s value justifies its price.
2019 年 11 月 21 日 PK Submit generates PK CDISC domains automatically, allowing sponsors to file regulatory submissions faster, while also improving data organization and compliance
Model-based meta-analysis is a quantitative framework that uses PK/PD and statistical modeling of external data to inform drug development decisions.
Nirpal Virdee, Synchrogenix’s Global Head of Transparency and Disclosure recently sat down with Trishna Bharadia, award-winning health advocate and patient engagement champion, for a discussion around patient engagement and patient centricity. Their discussion was moderated by Darshan Kulkarni of the podcast ‘Darshan Talks’ for a series of episodes that you can listen to here. Darshan … Continued
Certara will host two Phoenix WinNonlin™ Lunch and Learns and also lead 18 workshop, presentation and poster sessions on model-informed drug development
PRINCETON, NJ – Nov 1, 2019 – Certara thought leaders from its Evidence & Access division will present 12 posters at ISPOR Europe.